The Klinique Medical Clinic PCL (BKK:KLINIQ)
25.00
-1.75 (-6.54%)
At close: Mar 9, 2026
BKK:KLINIQ Cash Flow Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 364.05 | 322.19 | 288.62 | 205.49 | 129.26 | Upgrade
|
| Depreciation & Amortization | 333.12 | 282.3 | 194.61 | 142 | 81.19 | Upgrade
|
| Loss (Gain) From Sale of Assets | 5.98 | 5.17 | -0.03 | 0.44 | 2.29 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | -0 | -0.03 | - | Upgrade
|
| Other Operating Activities | -353.47 | -463.93 | -342.62 | -216.48 | -194.24 | Upgrade
|
| Change in Accounts Receivable | -5.42 | 5.08 | -9.56 | -1.41 | -0.59 | Upgrade
|
| Change in Inventory | -115.96 | -82.63 | -70.99 | -35.51 | 18.53 | Upgrade
|
| Change in Accounts Payable | 81.33 | 34.53 | 52.64 | 37.18 | 26.35 | Upgrade
|
| Change in Unearned Revenue | 414.38 | 451.73 | 326.59 | 334.25 | 183.82 | Upgrade
|
| Change in Other Net Operating Assets | -63.24 | -2.46 | -53.33 | -57.98 | -8.03 | Upgrade
|
| Operating Cash Flow | 660.77 | 551.98 | 385.92 | 407.96 | 238.56 | Upgrade
|
| Operating Cash Flow Growth | 19.71% | 43.03% | -5.40% | 71.01% | -3.91% | Upgrade
|
| Capital Expenditures | -300.15 | -571.67 | -366.52 | -225.79 | -72.92 | Upgrade
|
| Sale of Property, Plant & Equipment | 20.78 | 39.34 | 0.58 | - | 2.6 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.7 | -1.13 | -0.59 | -1.16 | -1.12 | Upgrade
|
| Investment in Securities | 128.03 | 529.37 | -60.1 | -1,000 | - | Upgrade
|
| Other Investing Activities | -5.58 | 19.89 | 5.26 | 0.52 | 20.06 | Upgrade
|
| Investing Cash Flow | -157.61 | 15.79 | -421.37 | -1,226 | -51.37 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -12.94 | Upgrade
|
| Long-Term Debt Repaid | -137.36 | -120.39 | -89.51 | -63.39 | -27.63 | Upgrade
|
| Total Debt Repaid | -137.36 | -120.39 | -89.51 | -63.39 | -40.57 | Upgrade
|
| Net Debt Issued (Repaid) | -137.36 | -120.39 | -89.51 | -63.39 | -40.57 | Upgrade
|
| Issuance of Common Stock | 20 | - | - | 1,470 | - | Upgrade
|
| Common Dividends Paid | -319 | -308 | -231 | -153.2 | -80 | Upgrade
|
| Other Financing Activities | - | - | - | -46.4 | - | Upgrade
|
| Financing Cash Flow | -436.36 | -428.39 | -320.51 | 1,207 | -120.57 | Upgrade
|
| Net Cash Flow | 66.8 | 139.38 | -355.96 | 388.54 | 66.62 | Upgrade
|
| Free Cash Flow | 360.62 | -19.7 | 19.39 | 182.17 | 165.64 | Upgrade
|
| Free Cash Flow Growth | - | - | -89.35% | 9.97% | 65.76% | Upgrade
|
| Free Cash Flow Margin | 10.14% | -0.66% | 0.85% | 11.11% | 17.44% | Upgrade
|
| Free Cash Flow Per Share | 1.64 | -0.09 | 0.09 | 1.07 | 1.03 | Upgrade
|
| Cash Interest Paid | - | 23.9 | 15.1 | 10.66 | 4.32 | Upgrade
|
| Cash Income Tax Paid | - | 64.42 | 55.28 | 35.39 | 22.17 | Upgrade
|
| Levered Free Cash Flow | 295.05 | -51.44 | -20.98 | 175.4 | 167.45 | Upgrade
|
| Unlevered Free Cash Flow | 311.51 | -36.5 | -11.54 | 182.06 | 170.15 | Upgrade
|
| Change in Working Capital | 311.08 | 406.25 | 245.35 | 276.53 | 220.06 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.